"10.1371_journal.ppat.1004473","plos pathogens","2014-11-13T00:00:00Z","Julian H Elliott; Fiona Wightman; Ajantha Solomon; Khader Ghneim; Jeffrey Ahlers; Mark J Cameron; Miranda Z Smith; Tim Spelman; James McMahon; Pushparaj Velayudham; Gregor Brown; Janine Roney; Jo Watson; Miles H Prince; Jennifer F Hoy; Nicolas Chomont; Rémi Fromentin; Francesco A Procopio; Joumana Zeidan; Sarah Palmer; Lina Odevall; Ricky W Johnstone; Ben P Martin; Elizabeth Sinclair; Steven G Deeks; Daria J Hazuda; Paul U Cameron; Rafick-Pierre Sékaly; Sharon R Lewin","Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia; Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia; Vaccine Gene Therapy Institute Florida, Port St Lucie, Florida, United States of America; National Association of People Living with HIV Australia, Sydney, New South Wales, Australia; Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia; Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Westmead Millenium Institute, University of Sydney, Westmead, New South Wales, Australia; Karolinska Institutet, Stockholm, Sweden; University of California San Francisco, San Francisco, California, United States of America; Merck Research Laboratories, West Point, Pennsylvania, United States of America","Conceived and designed the experiments: JHE SRL. Performed the experiments: JHE FW AS KG JA MJC MZS JM PV GB JR NC RF FAP JZ SP LO RWJ BPM ES PUC RPS SRL. Analyzed the data: JHE FW KG JA MJC TS JM NC RF FAP JZ. Wrote the paper: JHE FW AS KG JA MJC MZS TS JM PV GB JR JW MHP JFH NC RF FAP JZ SP LO RWJ BPM ES SGD DJH PUC RPS SRL.","JHE, JM and JR's institution has received funding for clinical research from Merck, Sharp & Dohme, Janssen-Cilag, Gilead Sciences, Bristol-Myers Squibb and ViiV Healthcare. JFH's institution has received funding for investigator-initiated research and service on Advisory Boards from Merck, Sharp & Dohme, Janssen-Cilag, Gilead Sciences, and ViiV Healthcare. JW has been a community member of a Merck Sharpe Dohme Advisory Board. MHP has undertaken paid consultancies for Merck. SGD has received grant support from Merck and Gilead. NC has received grant support from Merck. DJH is an employee of and has stock ownership in Merck Sharpe and Dohme. SRL's institution has received honoraria from Merck, Gilead, Viiv Healthcare, Janssen and Bristol Myers Squibb for participation in educational and consulting activities. She has received grants for investigator initiated research from Merck and Gilead. All other authors report no conflicts of interest.This does not alter our adherence to all PLOS policies on sharing data and materials.","2014","11","Julian H Elliott","JHE",29,TRUE,2,23,11,29,TRUE,TRUE,FALSE,0,NA,FALSE
